Generic Drugs And Patent For Pharmaceutical Research Legal Issues

Surge tide of economic globalization,China is gradually moving closer.Every industry and enterprise will inevitably be affected by this wave.and our country is called the eternal sunrise industry-pharmaceutical companies,but should also cause for concern.Integration in the global economy driven by intellectual property rights in an increasingly unified implementation of international standards of protection. generic drugs can no longer simply have to rely on the past and continue to copy the style to imitate to survive.With the largest share of patents in recent years due drugs and national pharmaceutical companies generic drugs brought about by huge profits, the status of generic drugs more and more important,due to technological level of China's economic development impact of pharmaceutical companies in our country for a long period of time the use of imitation and innovation as a supplement,a combination of imitation,which is by the decision of the actual situation in our country,but also by the practice of the feasible.In this paper,the starting point for generic drugs,generic drugs through the development and characteristics of the generic drugs and the importance of the legal status.Pharmaceutical patent protection in the main line to generic drugs and patent medicines based balance.On the one hand through the multi-level,comprehensive drug patent system to encourage investment,the protection of scientific research,promote technology transfer,from the pharmaceutical industry to fundamentally improve the level of scientific and technological research and development;on the other hand,the development of the production of generic drugs in favor of legal norms,it is necessary to protection of existing resources,drug patents,but also on the generic drug industry guide to simplify the review process for generic drugs,to clarify the patent dispute,the full lessons of the patent legislation of other countries to promote the development of generic drugs the content side,so that generic drugs can have s follow the law and reduce the risk of disputes and settlement of costs,to promote the healthy development of the pharmaceutical industry,nurture an internationally competitive enterprises.